BACKGROUND AND PURPOSE: Large admission DWI lesion volumes are associated with poor outcomes despite acute stroke treatment. The primary aims of our study were to determine whether CTA collaterals correlate with admission DWI lesion volumes in patients with AIS with proximal occlusions, and whether a CTA collateral profile could identify large DWI volumes with high specificity. MATERIALS AND METHODS: We studied 197 patients with AIS with M1 and/or intracranial ICA occlusions. We segmented admission and follow-up DWI lesion volumes, and categorized CTA collaterals by using a 5-point CS system. ROC analysis was used to determine CS accuracy in predicting DWI lesion volumes >100 mL. Patients were dichotomized into 2 categories: CS = 0 (malignant profile) or CS>0. Univariate and multivariate analyses were performed to compare imaging and clinical variables between these 2 groups. RESULTS: There was a negative correlation between CS and admission DWI lesion volume (ρ = -0.54, P < .0001). ROC analysis revealed that CTA CS was a good discriminator of DWI lesion volume >100 mL (AUC = 0.84, P < .001). CS = 0 had 97.6% specificity and 54.5% sensitivity for DWI volume >100 mL. CS = 0 patients had larger mean admission DWI volumes (165.8 mL versus 32.7 mL, P < .001), higher median NIHSS scores (21 versus 15, P < .001), and were more likely to become functionally dependent at 3 months (95.5% versus 64.0%, P = .003). Admission NIHSS score was the only independent predictor of a malignant CS (P = .007). CONCLUSIONS: In patients with AIS with PAOs, CTA collaterals correlate with admission DWI infarct size. A malignant collateral profile is highly specific for large admission DWI lesion size and poor functional outcome.
BACKGROUND AND PURPOSE: Large admission DWI lesion volumes are associated with poor outcomes despite acute stroke treatment. The primary aims of our study were to determine whether CTA collaterals correlate with admission DWI lesion volumes in patients with AIS with proximal occlusions, and whether a CTA collateral profile could identify large DWI volumes with high specificity. MATERIALS AND METHODS: We studied 197 patients with AIS with M1 and/or intracranial ICA occlusions. We segmented admission and follow-up DWI lesion volumes, and categorized CTA collaterals by using a 5-point CS system. ROC analysis was used to determine CS accuracy in predicting DWI lesion volumes >100 mL. Patients were dichotomized into 2 categories: CS = 0 (malignant profile) or CS>0. Univariate and multivariate analyses were performed to compare imaging and clinical variables between these 2 groups. RESULTS: There was a negative correlation between CS and admission DWI lesion volume (ρ = -0.54, P < .0001). ROC analysis revealed that CTACS was a good discriminator of DWI lesion volume >100 mL (AUC = 0.84, P < .001). CS = 0 had 97.6% specificity and 54.5% sensitivity for DWI volume >100 mL. CS = 0 patients had larger mean admission DWI volumes (165.8 mL versus 32.7 mL, P < .001), higher median NIHSS scores (21 versus 15, P < .001), and were more likely to become functionally dependent at 3 months (95.5% versus 64.0%, P = .003). Admission NIHSS score was the only independent predictor of a malignant CS (P = .007). CONCLUSIONS: In patients with AIS with PAOs, CTA collaterals correlate with admission DWI infarct size. A malignant collateral profile is highly specific for large admission DWI lesion size and poor functional outcome.
Authors: Daniel Sanák; Vladimír Nosál'; David Horák; Andrea Bártková; Kamil Zelenák; Roman Herzig; Jirí Bucil; David Skoloudík; Stanislav Burval; Viera Cisariková; Ivanka Vlachová; Martin Köcher; Jana Zapletalová; Egon Kurca; Petr Kanovský Journal: Neuroradiology Date: 2006-08-29 Impact factor: 2.804
Authors: Shahmir Kamalian; Shervin Kamalian; Matthew B Maas; Greg V Goldmacher; Seyedmehdi Payabvash; Adnan Akbar; Pamela W Schaefer; Karen L Furie; R Gilberto Gonzalez; Michael H Lev Journal: Stroke Date: 2011-05-05 Impact factor: 7.914
Authors: Gregory W Albers; Vincent N Thijs; Lawrence Wechsler; Stephanie Kemp; Gottfried Schlaug; Elaine Skalabrin; Roland Bammer; Wataru Kakuda; Maarten G Lansberg; Ashfaq Shuaib; William Coplin; Scott Hamilton; Michael Moseley; Michael P Marks Journal: Ann Neurol Date: 2006-11 Impact factor: 10.422
Authors: Jessica C Tan; William P Dillon; Songling Liu; Felix Adler; Wade S Smith; Max Wintermark Journal: Ann Neurol Date: 2007-06 Impact factor: 10.422
Authors: Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach Journal: Stroke Date: 2004-11-29 Impact factor: 7.914
Authors: Randall T Higashida; Anthony J Furlan; Heidi Roberts; Thomas Tomsick; Buddy Connors; John Barr; William Dillon; Steven Warach; Joseph Broderick; Barbara Tilley; David Sacks Journal: Stroke Date: 2003-07-17 Impact factor: 7.914
Authors: Max Wintermark; Gregory W Albers; Andrei V Alexandrov; Jeffry R Alger; Roland Bammer; Jean-Claude Baron; Stephen Davis; Bart M Demaerschalk; Colin P Derdeyn; Geoffrey A Donnan; James D Eastwood; Jochen B Fiebach; Marc Fisher; Karen L Furie; Gregory V Goldmakher; Werner Hacke; Chelsea S Kidwell; Stephan P Kloska; Martin Köhrmann; Walter Koroshetz; Ting-Yim Lee; Kennedy R Lees; Michael H Lev; David S Liebeskind; Leif Ostergaard; William J Powers; James Provenzale; Peter Schellinger; Robert Silbergleit; Alma Gregory Sorensen; Joanna Wardlaw; Ona Wu; Steven Warach Journal: AJNR Am J Neuroradiol Date: 2008-05 Impact factor: 3.825
Authors: E S Rosenthal; L H Schwamm; L Roccatagliata; S B Coutts; A M Demchuk; P W Schaefer; R G Gonzalez; M D Hill; E F Halpern; M H Lev Journal: AJNR Am J Neuroradiol Date: 2008-07-03 Impact factor: 3.825
Authors: Max Wintermark; Adam E Flanders; Birgitta Velthuis; Reto Meuli; Maarten van Leeuwen; Dorit Goldsher; Carissa Pineda; Joaquin Serena; Irene van der Schaaf; Annet Waaijer; James Anderson; Gary Nesbit; Igal Gabriely; Victoria Medina; Ana Quiles; Scott Pohlman; Marcel Quist; Pierre Schnyder; Julien Bogousslavsky; William P Dillon; Salvador Pedraza Journal: Stroke Date: 2006-03-02 Impact factor: 7.914
Authors: K Barlinn; J Seibt; K Engellandt; J Gerber; V Puetz; J Kepplinger; O Wunderlich; L-P Pallesen; U Bodechtel; R Koch; R von Kummer; I Dzialowski Journal: Clin Neuroradiol Date: 2014-08-23 Impact factor: 3.649
Authors: Brian P Walcott; Jennifer C Miller; Churl-Su Kwon; Sameer A Sheth; Marc Hiller; Carolyn A Cronin; Lee H Schwamm; J Marc Simard; Kristopher T Kahle; W Taylor Kimberly; Kevin N Sheth Journal: Neurocrit Care Date: 2014-08 Impact factor: 3.210
Authors: Shervin Kamalian; Andre Kemmling; Roderick C Borgie; Livia T Morais; Seyedmehdi Payabvash; Ana M Franceschi; Shahmir Kamalian; Albert J Yoo; Karen L Furie; Michael H Lev Journal: Stroke Date: 2013-08-29 Impact factor: 7.914
Authors: Achala Vagal; Bijoy K Menon; Lydia D Foster; Anthony Livorine; Sharon D Yeatts; Emmad Qazi; Chris d'Esterre; Junzi Shi; Andrew M Demchuk; Michael D Hill; David S Liebeskind; Thomas Tomsick; Mayank Goyal Journal: Stroke Date: 2015-12-10 Impact factor: 7.914
Authors: S E Beyer; K M Thierfelder; L von Baumgarten; M Rottenkolber; F G Meinel; H Janssen; B Ertl-Wagner; M F Reiser; W H Sommer Journal: AJNR Am J Neuroradiol Date: 2014-12-18 Impact factor: 3.825